Logo image
A phase II randomised control trial of high dose vitamin D in localised prostate cancer patients with intermediate risk of disease progression - ProsD Principal Investigator: Professor Howard Gurney
Abstract   Peer reviewed

A phase II randomised control trial of high dose vitamin D in localised prostate cancer patients with intermediate risk of disease progression - ProsD Principal Investigator: Professor Howard Gurney

V Nair-Shalliker, A Bang, S Egger, J Rodger, M Clements, R A Gardiner, A Kricker, M Seibel, S K Chambers, Michael G Kimlin, …
BJU International, Vol.122(Supplement 2), pp.30-31
Asia-Pacific Prostate Cancer Conference, 19th (Brisbane, Australia, 22-Aug-2018–25-Aug-2018)
2018
url
https://doi.org/10.1111/bju.14474View
Published Version

Abstract

Clinical Sciences
No abstract available.

Details

Metrics

212 Record Views
Logo image